001     910591
005     20221122131002.0
024 7 _ |a 2128/32691
|2 Handle
037 _ _ |a FZJ-2022-03969
041 _ _ |a English
100 1 _ |a Foerges, Anna Linea
|0 P:(DE-Juel1)179271
|b 0
|e Corresponding author
|u fzj
111 2 _ |a The 26th Conference of the European Sleep Research Society
|g Sleep Europe 2022
|c Athens
|d 2022-09-27 - 2022-09-30
|w Greece
245 _ _ |a Does repeated coffee consumption during chronic sleep restriction affect A1 adenosine receptor availability in humans?
260 _ _ |c 2022
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a CONFERENCE_POSTER
|2 ORCID
336 7 _ |a Output Types/Conference Poster
|2 DataCite
336 7 _ |a Poster
|b poster
|m poster
|0 PUB:(DE-HGF)24
|s 1669099251_13815
|2 PUB:(DE-HGF)
|x After Call
520 _ _ |a Objectives:Adenosine and cerebral adenosine A1 (A1AR) and A2A receptors are important modulators of the sleep-wake cycle and regulate to some extent the sleep-wake homeostasis. Acute sleep deprivation has been shown to result in an upregulation of A1ARs in human and rat brains. The stimulating effects of caffeine are evoked through non-selective antagonism at adenosine receptors. Using positron emission tomography (PET), we investigate the effect of repeated coffee consumption during chronic sleep restriction and subsequent coffee abstinence after recovery sleep on cerebral A1AR availability and occupancy in humans.Methods:Thirty healthy volunteers (28±5 years, 15f) completed an in-lab study including three [18F]CPFPX PET scans to determine cerebral A1AR availability after subsequent exposure to rested (3 nights with 8h time in bed (TIB)), chronically sleep restricted (5 nights with 5h TIB), and recovery (one night with 8h TIB) conditions. Participants either consumed freshly brewed coffee (n = 17) or decaffeinated coffee (n = 13) during 5 days of sleep restriction (prior caffeine abstinence > 10 days). Regular coffee contained 200 mg caffeine at 7.30 a.m. and 100 mg caffeine at 2.00 p.m., decaffeinated coffee contained 4 mg and 2 mg, respectively. PET scans were conducted at the same time of day under caffeine-abstinent rested conditions, roughly 7h after the latest coffee intake after sleep restriction, and after ~ 31h of coffee abstention after recovery. Caffeine levels in saliva were determined repeatedly. Cerebral A1AR availability was quantified by distribution volume (VT) and occupancy levels were calculated by applying the Lassen plot including cortical and subcortical areas, cerebellum, and pons.Results:In the decaffeinated coffee group, no differences in cerebral A1AR availability were found between baseline condition, 5 days of sleep restriction and one night of recovery sleep. Repeated administration of regular coffee resulted in a displacement of [18F]CPFPX binding of 19 ± 13 % on average. One day after coffee abstention and recovery sleep, VT values did not differ from baseline.Conclusions:Our data suggest that neither chronic sleep restriction for 5 days nor combination with repeated caffeine consumption result in a persistent change in the regulation of cerebral A1AR availability.Financial support:The work was supported by the Institute for Scientific Information on Coffee, the Swiss National Science Foundation (# 320030_163439) and respective institutional funds.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
700 1 _ |a Elmenhorst, Eva-Maria
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Lange, Denise
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Baur, Diego
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Beer, Simone
|0 P:(DE-Juel1)133864
|b 4
|u fzj
700 1 _ |a Kroll, Tina
|0 P:(DE-Juel1)131691
|b 5
|u fzj
700 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 6
|u fzj
700 1 _ |a Aeschbach, Daniel
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Bauer, Andreas
|0 P:(DE-Juel1)131672
|b 8
|u fzj
700 1 _ |a Landolt, Hans-Peter
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Elmenhorst, David
|0 P:(DE-Juel1)131679
|b 10
|u fzj
856 4 _ |u https://juser.fz-juelich.de/record/910591/files/Pierling_SleepEurope2022_Abstract.pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:910591
|p openaire
|p open_access
|p VDB
|p driver
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)179271
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)133864
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)131691
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 6
|6 P:(DE-Juel1)166419
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)131672
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 10
|6 P:(DE-Juel1)131679
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
914 1 _ |y 2022
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-2-20090406
|k INM-2
|l Molekulare Organisation des Gehirns
|x 0
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 1
980 _ _ |a poster
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-2-20090406
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21